+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug of Abuse Testing Market by Sample Type (Hair, Oral Fluid, Urine), Test Technology (Chromatography, Immunoassay), End User, Drug Panel - Global Forecast 2025-2030- Product Image
Drug of Abuse Testing Market by Sample Type (Hair, Oral Fluid, Urine), Test Technology (Chromatography, Immunoassay), End User, Drug Panel - Global Forecast 2025-2030- Product Image
Sale

Drug of Abuse Testing Market by Sample Type (Hair, Oral Fluid, Urine), Test Technology (Chromatography, Immunoassay), End User, Drug Panel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4896653
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global Drug of Abuse Testing Market is evolving rapidly, driven by changing substance misuse trends, regulatory developments, and technology advancements. Senior decision-makers face new challenges and opportunities as they shape strategies in a market characterized by diverse testing methods, complex supply chains, and region-specific adoption patterns.

Market Snapshot: Growth Dynamics in Drug of Abuse Testing

The Drug of Abuse Testing Market grew from USD 1.87 billion in 2024 to USD 2.01 billion in 2025. It is expected to continue growing at a CAGR of 7.31%, reaching USD 2.86 billion by 2030. Market expansion is supported by increased demand for accurate detection across clinical, forensic, and workplace environments. Parallel advances in analytical platforms and regulatory frameworks are driving adoption across key regions.

Scope & Segmentation of the Drug of Abuse Testing Market

  • Sample Types: Hair, oral fluid, and urine all present unique value propositions, from long-term detection to rapid, noninvasive sampling.
  • Test Technologies: Chromatography (including gas chromatography-mass spectrometry, liquid chromatography-mass spectrometry, tandem mass spectrometry, and high-resolution systems) and immunoassay technologies are shaping laboratory investments and result reliability.
  • End Users: Clinical laboratories, correctional facilities, forensic laboratories, and hospitals, each requiring distinct operational processes and compliance protocols.
  • Drug Panels: Custom panel configurations address organizational needs, while expanded, five, and ten-panel options support broader monitoring strategies.
  • Regional Coverage:
    • Americas: United States (including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina.
    • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland.
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan.
  • Key Companies: Thermo Fisher Scientific Inc., Roche Holding AG, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Bio-Rad Laboratories, Inc., Hologic, Inc., PerkinElmer, Inc., Sysmex Corporation, Becton, Dickinson and Company.

Key Takeaways for Senior Decision-Makers

  • Technological evolution is reshaping test accuracy and operational efficiency, with integrated analytical platforms and enhanced immunoassay formats gaining traction.
  • Decentralized testing models, including point-of-care systems and remote collection technology, are addressing the needs of clinical and correctional settings for faster decision-making.
  • Adaptation to shifting regulatory requirements and emerging substances is critical, encouraging continuous refinement of testing protocols and panel selection.
  • Supply chain resilience and collaborative vendor relationships are increasingly important, as procurement complexity grows and service providers adapt to new sourcing strategies.
  • Global variations in regulatory maturity and infrastructure are driving region-specific adoption, with North America leading technology deployment, EMEA focusing on harmonized frameworks, and Asia-Pacific emphasizing local reagent production.

Tariff Impact on Market Operations

Emerging United States tariff policies are influencing procurement of instrumentation, reagents, and consumables. Manufacturers and laboratories are revisiting sourcing strategies and exploring local partnerships to mitigate cost fluctuations and enhance supply chain robustness. Industry players are leveraging joint ventures, renegotiated supply contracts, and improved inventory management to stabilize operational continuity amid tariff-related uncertainties.

Methodology & Data Sources

The report is based on a blend of primary interviews and structured surveys with industry stakeholders, combined with secondary research from regulatory documents, technical literature, and peer-reviewed publications. Analytical frameworks were used to validate findings and contextualize strategic developments across the market landscape.

Why This Report Matters

  • Delivers actionable insights to support investment decisions, procurement planning, and risk mitigation in drug of abuse testing operations.
  • Offers a comprehensive, regionally nuanced analysis of technology trends, regulatory changes, and vendor strategies to guide long-term growth.
  • Equips executive teams with a structured roadmap for aligning laboratory practices with emerging standards and industry developments.

Conclusion

This analysis provides decision-makers with a clear view of the evolving drug of abuse testing market, highlighting strategic opportunities and industry challenges. By leveraging these insights, organizations can drive innovation and strengthen market positioning in a changing landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of high-sensitivity mass spectrometry for comprehensive drug screening in clinical settings
5.2. Expansion of decentralized point-of-care oral fluid testing for rapid detection of synthetic opioids at remote sites
5.3. Integration of AI-driven predictive analytics in laboratories to interpret drug metabolites and reduce false positives
5.4. Growing regulatory pressure for SAMHSA certification compliance driving adoption of standardized urine immunoassay panels
5.5. Surge in at-home multi-analyte test kits enabling employers to conduct remote pre-employment and ongoing screening
5.6. Development of multiplexed LC-MS/MS assays for simultaneous quantification of emerging synthetic cannabinoids and opioids
5.7. Increasing collaboration between telehealth providers and clinical labs to facilitate remote drug testing and monitoring programs
5.8. Rising demand for hair follicle analysis to detect long-term substance use patterns in forensic and clinical applications
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Drug of Abuse Testing Market, by Sample Type
8.1. Introduction
8.2. Hair
8.3. Oral Fluid
8.4. Urine
9. Drug of Abuse Testing Market, by Test Technology
9.1. Introduction
9.2. Chromatography
9.2.1. Gc-Ms
9.2.2. Lc-Ms
9.2.2.1. Lc-Ms/Ms
9.2.2.2. Lc-Qtof
9.3. Immunoassay
10. Drug of Abuse Testing Market, by End User
10.1. Introduction
10.2. Clinical Laboratory
10.3. Correctional Facility
10.4. Forensic Laboratory
10.5. Hospital
11. Drug of Abuse Testing Market, by Drug Panel
11.1. Introduction
11.2. Customized Panel
11.3. Expanded Panel
11.4. Five Panel
11.5. Ten Panel
12. Americas Drug of Abuse Testing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Drug of Abuse Testing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Drug of Abuse Testing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Roche Holding AG
15.3.3. Abbott Laboratories
15.3.4. Siemens Healthineers AG
15.3.5. Danaher Corporation
15.3.6. Bio-Rad Laboratories, Inc.
15.3.7. Hologic, Inc.
15.3.8. PerkinElmer, Inc.
15.3.9. Sysmex Corporation
15.3.10. Becton, Dickinson and Company
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. DRUG OF ABUSE TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. DRUG OF ABUSE TESTING MARKET: RESEARCHAI
FIGURE 24. DRUG OF ABUSE TESTING MARKET: RESEARCHSTATISTICS
FIGURE 25. DRUG OF ABUSE TESTING MARKET: RESEARCHCONTACTS
FIGURE 26. DRUG OF ABUSE TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DRUG OF ABUSE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY GC-MS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY GC-MS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS/MS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS/MS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LC-QTOF, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LC-QTOF, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICAL LABORATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CLINICAL LABORATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CORRECTIONAL FACILITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CORRECTIONAL FACILITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY FORENSIC LABORATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY FORENSIC LABORATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CUSTOMIZED PANEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY CUSTOMIZED PANEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY EXPANDED PANEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY EXPANDED PANEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY FIVE PANEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY FIVE PANEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY TEN PANEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DRUG OF ABUSE TESTING MARKET SIZE, BY TEN PANEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 83. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 84. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 85. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 86. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 87. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 88. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 89. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 90. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 91. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 94. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 95. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 96. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 97. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 98. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 99. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 100. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 101. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 102. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 103. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 106. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 107. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 108. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 146. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 157. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 158. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 159. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 160. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 161. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 162. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 163. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 164. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 165. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 168. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 169. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 170. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 171. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 172. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 173. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 174. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 175. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 176. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 177. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 180. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 181. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 182. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 193. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 194. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 195. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 198. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 199. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 200. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 201. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 204. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 205. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 206. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 207. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 210. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 211. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 212. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 213. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 216. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 230. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 242. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 253. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 254. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 255. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 256. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 257. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 258. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 259. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 260. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 261. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 264. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 265. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 266. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 277. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 278. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 279. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 280. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 281. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 282. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 283. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 284. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 285. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 288. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 289. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 290. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 291. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 292. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 293. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 294. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 295. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 296. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 297. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 300. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 301. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 302. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 313. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 314. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 324. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 325. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 326. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 327. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 328. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 329. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 330. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 331. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2018-2024 (USD MILLION)
TABLE 332. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY LC-MS, 2025-2030 (USD MILLION)
TABLE 333. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 335. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2018-2024 (USD MILLION)
TABLE 336. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG PANEL, 2025-2030 (USD MILLION)
TABLE 337. TURKEY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 338. TURKEY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 339. TURKEY DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 340. TURKEY DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 341. TURKEY DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 342. TURKEY DRUG OF ABUSE TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 343. TURKEY DRUG OF ABUSE

Samples

Loading
LOADING...

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Roche Holding AG
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Hologic, Inc.
  • PerkinElmer, Inc.
  • Sysmex Corporation
  • Becton, Dickinson and Company

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.01 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.86 Billion
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

At-home Drug of Abuse Testing Market by Distribution Channel (Online, Pharmacy Retail), Test Type (Multi-Drug Panel, Single Drug), Sample Type, Technology, End User - Global Forecast 2025-2030 - Product Image

At-home Drug of Abuse Testing Market by Distribution Channel (Online, Pharmacy Retail), Test Type (Multi-Drug Panel, Single Drug), Sample Type, Technology, End User - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Drugs of Abuse Testing - Global Strategic Business Report - Product Image

Drugs of Abuse Testing - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Drugs of Abuse Testing Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Drugs of Abuse Testing Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Drug of Abuse Testing Market (By Product Type, Sample / Test Type, Drug Type, End Users / Setting Type, Country Analysis), Regulatory Status, Recent Developments, Company Profiles - Forecast to 2032 - Product Image

Drug of Abuse Testing Market (By Product Type, Sample / Test Type, Drug Type, End Users / Setting Type, Country Analysis), Regulatory Status, Recent Developments, Company Profiles - Forecast to 2032

  • Report
  • 235 Pages
  • Global
From
Drug of Abuse Testing Market by Product Type, Sample, Drug, and End User - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035 - Product Image

Drug of Abuse Testing Market by Product Type, Sample, Drug, and End User - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035

  • Report
  • 220 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.